IP Library Granted Patent US 9,308,157
Granted Patent B2
US 9,308,157 · App. 14/288,791 · Granted Apr 12, 2016

Whitening cosmetic

Inventors: Yoshinobu Takino (Kawasaki, JP); Fumie Okura (Kawasaki, JP); Shinji Kuroda (Kawasaki, JP)
Assignee: AJINOMOTO CO., INC.
A61K8/49A61K8/361A61K8/368A61K8/44A61K8/498A61K8/4973A61K8/602A61K8/64A61K8/97A61K31/426A61Q19/02A61K8/445
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,308,157
App. No.
14/288,791
Granted
Apr 12, 2016
Kind
B2
Abstract

Compositions, comprising (A) a cysteine derivative represented by the formula (I) or a salt thereof: wherein X and Y are each independently OR 1 or NHR 2 wherein R 1 and R 2 are each independently a hydrogen atom or a C 1-22 alkyl group; Z is a hydrogen atom or a C 1-22 alkyl group; and W is a C 1-22 alkyl group, a C 1-22 alkoxy group or a C 1-22 alkylamino group, and (B) a whitening agent, are useful for whitening skin and reducing melanin production.

Claims (40)

1. A cosmetic agent, comprising:

(A) at least one cysteine compound represented by formula (I) or a salt thereof:

wherein

X and Y are each independently OR 1 or NHR 2 wherein R 1 and R 2 are each independently a hydrogen atom or a C 1-22 alkyl group;

Z is a hydrogen atom or a C 1-22 alkyl group; and

W is a C 1-22 alkyl group, a C 1-22 alkoxy group or a C 1-22 alkylamino group; and

(B) at least one whitening agent,

wherein:

(A) said at least one cysteine compound or a salt thereof is one or more members selected from the group consisting of N-acetyl-2-methylthiazolidine-2,4-dicarboxylic acid, a salt of N-acetyl-2-methylthiazolidine-2,4-dicarboxylic acid, N-acetyl-2-methylthiazolidine-2,4-dicarboxylic acid 2-ethyl ester, and a salt of N-acetyl-2-methylthiazolidine-2,4-dicarboxylic acid 2-ethyl ester; and

(B) said at least one whitening agent is one or more members selected from the group consisting of arbutin, cetyl ascorbyl ether, kojic acid, 4-methoxy salicylic acid, chamomilla recutita extract, ellagic acid, linoleic acid, glutathione, tranexamic acid, 4-n-butylresorcinol, and 4-hexylresorcinol.

2. The cosmetic agent according to claim 1 , wherein (B) said at least one whitening agent is one or more members selected from the group consisting of arbutin, kojic acid, 4-methoxy salicylic acid, chamomilla recutita extract, glutathione, and tranexamic acid.

3. The cosmetic agent according to claim 1 , wherein (B) said at least one whitening agent is one or more members selected from the group consisting of arbutin, kojic acid, chamomilla recutita extract, tranexamic acid.

4. The cosmetic agent according to claim 1 , wherein (A) said at least one cysteine compound or a salt thereof is N-acetyl-2-methylthiazolidine-2,4-dicarboxylic acid 2-ethyl ester or a salt thereof, and (B) said at least one whitening agent is kojic acid.

5. The cosmetic agent according to claim 1 , wherein (A) said at least one cysteine compound or a salt thereof is N-acetyl-2-methylthiazolidine-2,4-dicarboxylic acid 2-ethyl ester or a salt thereof, and (B) said at least one whitening agent is tranexamic acid.

6. The cosmetic agent according to claim 1 , wherein (A) said at least one cysteine compound or a salt thereof is N-acetyl-2-methylthiazolidine-2,4-dicarboxylic acid 2-ethyl ester or a salt thereof, and (B) said at least one whitening agent is a chamomilla recutita extract.

7. The cosmetic agent according to claim 1 , wherein (A) said at least one cysteine compound or a salt thereof is N-acetyl-2-methylthiazolidine-2,4-dicarboxylic acid 2-ethyl ester or a salt thereof, and (B) said at least one whitening agent is arbutin.

8. The cosmetic agent according to claim 1 , wherein (A) said at least one cysteine compound or a salt thereof and (B) said at least one whitening agent are present in a mass ratio of (A)/(B)=1/20-5000/1 (g/g).

9. The cosmetic agent according to claim 1 , wherein (A) said at least one cysteine compound represented by formula (I) is one or more members selected from the group consisting of a (2R,4S)-form, a (2S,4R)-form, and a mixture thereof.

10. The cosmetic agent according to claim 1 , wherein (A) said at least one cysteine compound represented by formula (I) is a (2S,4R)-form.

11. A melanin production suppressive agent, comprising:

(A) at least one cysteine compound represented by formula (I) or a salt thereof:

wherein

X and Y are each independently OR 1 or NHR 2 wherein R 1 and R 2 are each independently a hydrogen atom or a C 1-22 alkyl group;

Z is a hydrogen atom or a C 1-22 alkyl group; and

W is a C 1-22 alkyl group, a C 1-22 alkoxy group or a C 1-22 alkylamino group; and

(B) at least one whitening agent

wherein:

(A) said at least one cysteine compound or a salt thereof is one or more members selected from the group consisting of N-acetyl-2-methylthiazolidine-2,4-dicarboxylic acid, a salt of N-acetyl-2-methylthiazolidine-2,4-dicarboxylic acid, N-acetyl-2-methylthiazolidine-2,4-dicarboxylic acid 2-ethyl ester, and a salt of N-acetyl-2-methylthiazolidine-2,4-dicarboxylic acid 2-ethyl ester; and

(B) said at least one whitening agent is one or more members selected from the group consisting of arbutin, cetyl ascorbyl ether, kojic acid, 4-methoxy salicylic acid, chamomilla recutita extract, ellagic acid, linoleic acid, glutathione, tranexamic acid, 4-n-butylresorcinol, and 4-hexylresorcinol.

12. The melanin production suppressive agent according to claim 11 , wherein (B) said at least one whitening agent is one or more members selected from the group consisting of arbutin, kojic acid, 4-methoxy salicylic acid, chamomilla recutita extract, glutathione, and tranexamic acid.

13. The melanin production suppressive agent according to claim 11 , wherein (A) said at least one cysteine compound represented by formula (I) is one or more members selected from the group consisting of a (2R,4S)-form, a (2S,4R)-form, and a mixture thereof.

14. The melanin production suppressive agent according to claim 11 , wherein (A) said at least one cysteine derivative represented by formula (I) is a (2S,4R)-form.

15. A method of suppressing melanin production, comprising administering to a subject in need thereof an effective amount of a cosmetic agent according to claim 1 .

16. A method according to claim 15 , wherein said administering is topical administering.

17. A method of whitening skin, comprising administering to a subject in need thereof an effective amount of a cosmetic agent according to claim 1 .

18. A method according to claim 17 , wherein said administering is topical administering.

19. A method of suppressing melanin production, comprising administering to a subject in need thereof an effective amount of a cosmetic agent according to claim 2 .

20. A method according to claim 19 , wherein said administering is topical administering.

21. A method of whitening skin, comprising administering to a subject in need thereof an effective amount of a cosmetic agent according to claim 2 .

22. A method according to claim 21 , wherein said administering is topical administering.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 20, 2014
From: TAKINO, YOSHINOBU; OKURA, FUMIE; KURODA, SHINJI
To: AJINOMOTO CO., INC.
Reel/Frame 033573/0751 →
Priority Claims (1)
JP 2011-262164 · Nov 30, 2011 · national
Continuity (2)
Continuation PCTJP2012081192 · Nov 30, 2012
Related Publication 20140271510A1 · Sep 18, 2014